Singapore markets closed

Biolidics Limited (8YY.SI)

SES - SES Delayed price. Currency in SGD
Add to watchlist
0.0110+0.0010 (+10.00%)
At close: 05:04PM SGT
Currency in SGD

Valuation measures4

Market cap (intra-day) 8.19M
Enterprise value 9.66M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)26.30
Price/book (mrq)N/A
Enterprise value/revenue 35.52
Enterprise value/EBITDA -3.02

Trading information

Stock price history

Beta (5Y monthly) 0.70
52-week change 3-31.25%
S&P500 52-week change 318.96%
52-week high 30.0180
52-week low 30.0090
50-day moving average 30.0104
200-day moving average 30.0121

Share statistics

Avg vol (3-month) 32.17M
Avg vol (10-day) 32.21M
Shares outstanding 5744.76M
Implied shares outstanding 6744.76M
Float 8447.38M
% held by insiders 145.95%
% held by institutions 10.00%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)-687.50%

Management effectiveness

Return on assets (ttm)-66.89%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)363k
Revenue per share (ttm)0.00
Quarterly revenue growth (yoy)-89.90%
Gross profit (ttm)N/A
EBITDA -2.93M
Net income avi to common (ttm)-2.9M
Diluted EPS (ttm)-0.0000
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)223k
Total cash per share (mrq)0
Total debt (mrq)1.69M
Total debt/equity (mrq)N/A
Current ratio (mrq)0.24
Book value per share (mrq)-0.00

Cash flow statement

Operating cash flow (ttm)-2.28M
Levered free cash flow (ttm)-3.43M